Kaiyi Sun
Ning Wang1
Lu Gao- 1Department of Physiology, College of Basic Medical Sciences, Naval Medical University, Shanghai, China
- 2Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai Jiaotong University, Shanghai, China
1 Introduction
The occurrence of labor is a highly coordinated process involving multiple physiological systems. Abnormal parturition can result in adverse pregnancy outcomes, including preterm birth (PTB), dystocia, and post-term birth, which directly impact the health and survival of both the mother and the fetus (Chawanpaiboon et al., 2019). Among these, PTB is one of the most prevalent pregnancy complications, affecting approximately 5%–18% of pregnant women worldwide and significantly increasing the risk of neonatal morbidity and mortality (Romero et al., 2014).
Non-genetic risk factors for PTB include inflammation, immune-related pathways and abnormalities in decidual structure or function. However, advancing research has identified genetic and epigenetic factors that also modulate the functions of various tissues within maternal and fetal systems. Moreover, interactions between genetic/epigenetic factors and environmental influences, such as obesity and smoking, have been implicated in PTB, underscoring their significance in parturition (Li et al., 2022). Therefore, systematically summarizing existing research and exploring the mechanisms underlying the initiation of labor and PTB will provide an effective foundation for PTB prevention and treatment.
2 Maternal genetic factors contributing to labor
Genome-wide association studies (GWAS), along with expanded whole-exome sequencing (WES) and whole-genome sequencing (WGS), have provided powerful tools for identifying genetic pathways related to birth timing and PTB. A Large-scale GWAS has identified several maternal genetic variants loci associated with gestational duration and PTB risk, including EBF1, EEFSEC, AGTR2, WNT4, ADCY5, and RAP2C (Zhang et al., 2017). Some of these loci have also been validated in cohort studies of spontaneous preterm birth (sPTB) (Ehret et al., 2011; Jain et al., 2022). However, GWAS research on PTB remains limited, primarily due to the small scale or restrictions of single ethnic groups or geographical regions, leading to a lack of replication, particularly in high-risk sPTB populations.
Genetically engineered mouse models offer a valuable approach for elucidating the mechanisms of genetic disorders. In CXCR3-deficient mice, the sPTB-associated cytokines were not increased acutely in amniotic fluid following the injection of lipopolysaccharide (LPS) at a preterm birth-inducing dose, suggesting that CXCR3 contributes to sPTB (Karjalainen et al., 2015). Hirota et al. conditionally knocked out the Trp53 gene in mouse uteri using Pgr-cre and found that Trp53-deficient mice exhibited a significant predisposition to PTB, with approximately 50% delivering as early as embryonic day 16.5 (Hirota et al., 2010). Since Trp53 (TP53 in human) is a classical aging-related gene, this finding also provides insight into the increased PTB risk observed in older pregnant women (Supplementary Table S1).
3 Fetal genetic factors contributing to labor
Although the maternal genome exerts a predominant influence on gestational duration and PTB occurrence, emerging evidence suggests that fetal genetic factors also play a critical role. A previous study from our group demonstrated that wild-type female mice mated with male mice deficient in steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2) exhibited significantly reduced secretion of surfactant protein A (SP-A) and platelet-activating factor (PAF) in fetal lung, leading to a severe delay in parturition of approximately 38 h by attenuating the inflammatory pathway in the myometrium (Gao et al., 2015), which highlighted the significant roles of fetus-derived factors in triggering the initiation of labor in murine model. Interestingly, a high-resolution metabolic profile covering the whole gestational period has revealed the metabolic characteristics of pregnant women and facilitated the construction of a metabolic clock for predicting gestational age. This study found that the plasma level of PAF increases according to human gestational age (Liang et al., 2020), suggesting that the dynamic changes of PAF may be closely associated with parturition in human as well. Moreover, another study demonstrated that PAF in fetal cord blood from term not in labor women was significantly higher than that from preterm not in labor women, which was further increased in term in labor women. Of more interest, it was found that concentrations of PAF from umbilical venous blood were significantly lower than umbilical arterial blood from the same patients, further confirming our previous findings in mouse model that the increased PAF are contributed primarily by the fetus, other than from the maternal side. Furthermore, PAF can induce DNA methylation in the promoter region of the progesterone receptor (PR-A) in human placental tissue, leading to the suppression of PR-A transcription, which may represent a non-classical functional progesterone withdrawal mechanism comparing to that in myometrium (Palomares et al., 2021). These follow-up researches, combined with our original findings, strongly suggest that fetus-derived PAF plays critical roles in triggering parturition in both mouse and human, although the underlying mechanisms may differ between mouse and human.
In a study of Finnish families with multiple cases of sPTB identified a genetic linkage between sPTB and specific genes encoding the insulin-like growth factor 1 receptor (IGF1R) and androgen receptor (AR) in fetal genome. These findings were replicated in case-control studies of another Finnish sPTB cohort (Haataja et al., 2011; Karjalainen et al., 2012; Aguirre et al., 2016). Additionally, a large-scale GWAS conducted on infants born preterm, identified a fetal locus on chromosome 2q13 as a crucial region associated with labor onset (Liu et al., 2019) (Supplementary Table S1). These findings suggest that fetal genetic factors also play a critical role in regulating parturition. Future genetic studies on PTB should comprehensively consider the contributions of both maternal and fetal genomes.
4 Epigenetic regulation of term or preterm labor timing
4.1 MicroRNA
During late pregnancy or near delivery, the upregulation of oestradiol-17β (E2) suppresses the expression of zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2). This suppression results in an increased expression of the miR-200 family, which in turn inhibits the activation of signal transducer and activator of transcription 5B (STAT5B). Subsequently, this process enhances the expression of progesterone-metabolizing enzyme 20α-hydroxysteroid dehydrogenase (20α-HSD), reducing the local progesterone levels and ultimately triggering labor (Williams et al., 2012). Simultaneously, the suppression of ZEB1 decreases the expression of miR-199a-3p and miR-214, in turn leading to the increase in expression of cyclooxygenase-2 (COX-2), which promotes myometrial contraction and preterm labor (Renthal et al., 2010). Towards the end of labor, the enhancement of estradiol-17β/ERα signaling pathway in myometrium suppresses the expression of miR-181a. The reduction in miR-181a levels, in turn, upregulates the expression of estrogen receptors-α (ERα), tumor necrosis factor α (TNF-α), and other pro-inflammatory cytokines, which may contribute to the initiation of preterm birth (Gao et al., 2016).
A range of microRNAs exhibiting significant differential expression have been identified in the serum of pregnant women experiencing PTB, including miR-200a, miR-4695-5p, miR-665, and miR-887 (Elovitz et al., 2015). However, the expression patterns of some miRNAs in the serum of PTB cases do not align with phenotypes observed in animal models. For example, in murine models, the upregulation of miR-200a enhances local progesterone metabolism and suppresses ZEB1/2 expression, thereby increasing myometrial contractility and promoting the transcription of genes involved in uterine contraction (Renthal et al., 2010; Williams et al., 2012; Renthal et al., 2013). In contrast, a downregulation of miR-200a has been observed in the serum of women with PTB, albeit to a lesser extent (Elovitz et al., 2015). Due to the complexity of gene mutations and interspecies homology differences, mouse models may not always accurately mimic human phenotypes (Supplementary Table S1). Therefore, while numerous miRNAs have been implicated in the regulation of labor onset and PTB, it is essential to consider the conservation and divergence of regulatory mechanisms across different tissues, organs, and species when extrapolating findings from model organisms to human physiology.
4.2 LncRNA
Long non-coding RNAs (lncRNAs) play a crucial role in preterm premature rupture of membranes (PPROM) by regulating the mRNA levels in pathways associated with extracellular matrix (ECM) remodeling, apoptosis, actin cytoskeleton organization, and smooth muscle contraction (Luo et al., 2015). The expression of lncRNA 504601 and CR602937 is significantly upregulated in patients with PPROM, leading to a downregulation of collagen family members COL1A1 and COL18A1. Since these collagens are directly involved in ECM formation and remodeling, their degradation is a major factor contributing to fetal membrane reconstruction and may underlie the pathogenesis of PPROM (Zhao et al., 2017).
Zhou et al. identified five circadian rhythm-associated lncRNAs (INC00893, LINC00265, LINC01089, LINC00482, and LINC00649) that were significantly downregulated in the placenta of sPTB cases by analyzing two independently published RNA datasets (GSE73712 and GSE174415) (Zhou et al., 2022). These findings suggest a correlation between changes in lncRNA expression levels and the occurrence of preterm birth (Supplementary Table S1). However, further research is required to elucidate the regulatory mechanisms underlying lncRNA expression, which may provide reliable evidence for developing specific therapeutic targets for preterm birth prevention and management.
4.3 DNA methylation
In the amnion of preterm patients, the promoter region of the oxytocin receptor (OXTR), a classical contraction-associated protein, exhibits increased DNA methylation levels (Kim et al., 2013). Given that DNA methylation generally plays a role in gene silencing, although the expression of OXTR significantly increased near labor, the DNA methylation observed in OXTR gene may not correlate with OXTR expression. Moreover, the CpG island of solute carrier family 30 member 3 (SLC30A3) also exhibits hypermethylation in the amnion of preterm patients, leading to reduced expression of SLC30A3 (Kim et al., 2013). As a zinc transporter, the dysregulated expression of SLC30A3 may disrupt nutritional homeostasis during pregnancy, ultimately leading to PTB. In amnion fibroblasts from patients with PPROM, a decrease of methylation levels in the MMP1 gene promoter region has been observed, resulting in a marked increase in transcription of MMP1 gene. MMP1 facilitates the degradation of fibrillar collagen, which is associated with the breakdown of the extracellular matrix of the fetal membranes (Wang et al., 2008). The differential regulatory patterns of DNA methylation across various tissues during pregnancy provide epigenetic insights into the timing of labor and the occurrence of preterm birth (Supplementary Table S1).
4.4 Histone modification
During labor, activating histone modifications such as H3K4me3 (trimethylated histone H3 lysine 4) and H3/H4 acetylation occur in the PR-A promoter region of myometrium, leading to an upregulation of PR-A mRNA levels. This results in an increased PR-A/PR-B ratio in the myometrium, as PR-B mediates the classical actions of progesterone, including the maintenance of myometrial quiescence, while PR-A acts as an inhibitor of progesterone action mediated by PR-B and the functional withdrawal of progesterone is mediated by the enhanced expression ratio of PR-A/PR-B (Pieber et al., 2001), which characterizes myometrial activation and the initiation of labor (Chai et al., 2012). The dissociation of JARID1A from the PR-A promoter facilitates H3K4 trimethylation and histone acetylation, thereby enhancing PR-A expression in the myometrium and further elevating the PR-A/PR-B ratio. This mechanistic process explains the increased H3K4me3 levels and PR-A expression observed in both term and preterm labor (Chai et al., 2014). Another study reported that the expression of histone deacetylase HDAC1 gradually decreases throughout pregnancy and HDAC1 can bind to the PR-A promoter region, thereby upregulating PR-A expression (Ke et al., 2016). These findings suggest that histone methylation or acetylation may contribute to progesterone functional withdrawal, a critical process in human parturition.
For years, research on parturition timing has primarily focused on proximal triggers of labor onset in late pregnancy. Recent studies have revealed that histone demethylase KDM6B regulates H3K27me3 levels in uterine fibroblasts during early pregnancy (GD 0.5–GD 5.5) in mice. In KDM6B-deficient mice, excessive accumulation of H3K27me3 at multiple genomic loci led to transcriptional alterations in late pregnancy, including dysregulation of Ptgs1, COX-1, PGF2α and Akr1c18, as well as delayed serum P4 decline, ultimately resulting in 1–3 days delay in parturition (McIntyre et al., 2025). This interesting study sheds new light that epigenetic regulation during early pregnancy may provide reliable evidence for the early prediction of parturition timing or PTB risk (Supplementary Table S1).
4.5 The association between epigenetic alterations in maternal diseases and preterm birth
Maternal disorders such as pre-eclampsia (PE), gestational diabetes mellitus (GDM), and intrauterine infections are the leading causes of iatrogenic PTB, which can independently alter widespread epigenomics, highlighting the complex interplay between maternal health and epigenomic regulation during pregnancy (Vogel et al., 2018).
PE is the major cause of maternal mortality in developed countries and contributes significantly to iatrogenic PTB and low birthweight infants, affecting approximately 3%–5% of pregnant women (Dimitriadis et al., 2023). Studies have shown that DNA methylation in the promoter region of TIMP3 is significantly reduced in the placentas of women with PE (Cruz et al., 2022). However, some studies observed higher whole DNA methylation in placentas from women with PE (both term and preterm labor) when compared with normotensive women, whereas no association of placental methylation patterns with birth outcome (Kulkarni et al., 2011). Despite conflicting findings regarding whole DNA methylation levels in the placentas of PE largely attributable to methodological differences, no definitive association of placental DNA methylation patterns with birth outcomes has been established. (Kulkarni et al., 2011). Pineles et al. were the first to report seven differentially expressed miRNAs in placentas from women with PE who delivered either normal infants or small-for-gestational-age (SGA) infants. Notably, miR-210 and miR-182 were significantly upregulated in women with PE and PE + SGA compared to those with sPTB (Pineles et al., 2007). MiR-374a-5p and miR-191-5p have been implicated in both PE and PTB, suggesting a possible molecular connection between the two conditions (Subramanian et al., 2023). In addition, histone modifications such as H3K4me3, H3K9ac, and H3K27me3 were significantly reduced in the placentas of women with PE, independent of fetal sex (Meister et al., 2021; Deng et al., 2023). However, the epigenetic mechanisms linking PE to PTB remain underexplored, underscoring the need for more studies to provide definitive and clinically relevant epigenomic evidence (Supplementary Table S1).
Gestational diabetes mellitus (GDM) is another common pregnancy complication strongly associated with PTB and other adverse outcomes. Epigenomic alterations in various tissues and cells have been shown to play pivotal roles in GDM pathogenesis and may influence long-term health in offspring (Abu Samra et al., 2022). A study focusing on African American women found that methylation of the CYTIP and LINC00114 gene promoters in whole blood was associated with PTB in the context of GDM. These modifications may promote inflammatory signaling and premature uterine contractility, thus triggering preterm labor (Hong et al., 2018). Furthermore, analyses of umbilical cord blood and tissue from preterm infants suggest a prominent role for DNA methylation in immune and inflammatory pathways (Wu et al., 2019). Epigenetically modified genetic material in GDM pregnancies may contribute to PTB by enhancing inflammatory responses, supporting the concept that maternal metabolic and immune status directly influences birth timing through epigenetic regulation (Supplementary Table S1).
5 Genetic-based screening strategies for prediction of preterm birth
Given the association between maternal genetic factors and preterm birth, as well as the exclusive maternal inheritance of mitochondrial DNA (mtDNA) mutations, which have been linked to various hereditary diseases, Yang et al. established an automated pipeline for detecting mitochondrial DNA (mtDNA) mutations using low-coverage whole-genome sequencing (lcWGS) data. Applying lcWGS to a cohort of 929 PTB samples (21–30 weeks) from diverse ethnic backgrounds, they identified mtDNA variants potentially contributing to PTB, including known pathogenic variants in 8 cases and rare variants in 47 cases (Yang et al., 2021). This study provides an alternative genetic screening approach for investigating parturition and PTB.
Clinical studies have documented that cell-free fetal DNA (cfDNA) levels increase with gestational age and peak at the end of pregnancy (Phillippe, 2014). Additionally, research has shown that the plasma cfDNA concentration in women undergone preterm labor is twice that of those undergone term (Leung et al., 1998). Furthermore, studies also have demonstrated that patients with abnormally elevated cfDNA levels in mid-pregnancy face a significantly increased risk of sPTB in late pregnancy (Jakobsen et al., 2012). These findings indicate cfDNA can serve as a potential biomarker for labor initiation. The underlying mechanism likely involves the activation of pattern recognition receptors, such as Toll-like receptor 9 (TLR9) or other DNA-sensing pathways, including the STING signaling pathway, by freely circulating hypomethylated DNA, subsequently triggering downstream cascades leading to labor onset (Bauer et al., 2006; Fűri et al., 2015; van Boeckel et al., 2018). As a result, the application of cfDNA provides a non-invasive genetic screening approach for PTB prediction, substantially reducing the need for invasive diagnostic procedures such as amniocentesis while offering objective evidence for early medical intervention, thereby contributing to improved PTB prevention strategies (Tarca et al., 2021).
In recent years, non-invasive prenatal testing has expanded to measurements of circulating RNA in whole blood or plasma cell-free RNA (cfRNA) (Moufarrej et al., 2020). Large-cohort studies have successfully identified women at risk of preterm birth over 2 months in advance by measuring cfRNA levels, demonstrating the predictive potential of cfRNA for labor timing. However, existing studies have primarily focused on spontaneous preterm birth within specific ethnic groups, necessitating larger-scale validation and longitudinal studies across diverse populations to enhance the clinical applicability of cfRNA (Ngo et al., 2018). In another prospective study, maternal blood samples were collected during mid-pregnancy for cfRNA analysis, leading to the establishment of a cfRNA transcriptomic profile. This study identified multiple transcripts and regulatory pathways associated with sPTB, including extracellular matrix organization and degradation pathways and the insulin-like growth factor signaling pathway (Camunas-Soler et al., 2022). These findings provide an extensive time window for clinical intervention, as early pregnancy plasma cfRNA measurements could offer predictive insights into late-gestation clinical outcomes. Specifically, our recent study by analyzing public cfRNA database revealed that the cfRNA levels of TNFSF4 in maternal peripheral blood are elevated during preterm labor compared to term labor, suggesting the TNFSF4 could serve as a novel cfRNA biomarker for non-invasive prenatal diagnosis of preterm birth (Wang et al., 2023). However, its specificity and sensitivity require further validation with additional clinical data.
6 Conclusion
The prevention and management of PTB remain global challenges. Investigating genetic and epigenetic alterations associated with parturition initiation and PTB will enhance our understanding of the molecular mechanisms underlying sPTB and its long-term health consequences for offspring. It is increasingly evident that both genomic and epigenomic changes play crucial roles in the pathogenesis of PTB. Although advances in high-throughput technologies have generated vast amounts of data and identified numerous potential genetic and epigenetic loci for diagnosis and prevention of PTB, the lack of effective integration of global genomic data due to the volume and complexity may limit their translation into clinical practice. Therefore, leveraging artificial intelligence to integrate and model these large-scale genomic datasets holds great promise for the development of precise screening, diagnostic, and therapeutic strategies for PTB. In addition, despite growing evidence supporting the role of epigenetic modifications in the etiology of PTB, the dynamic nature of the epigenome during the prolonged and complex course of pregnancy and the high cost of testing have hindered the widespread clinical adoption of epigenomic analysis. Carter et al. have proposed the development of a commercially available, affordable, and standardized chromatin DNA reference sample to serve as a benchmark or threshold, which would enhance the standardization and reliability of epigenomic testing and facilitate its broader clinical implementation (Carter et al., 2023). In the future, the establishment of genetic and epigenetic monitoring studies spanning the entire gestational period could facilitate the identification of valuable genetic and epigenetic biomarkers, ultimately improving PTB prediction and prevention efforts.
Author contributions
KS: Writing – original draft. NW: Writing – review and editing, Data curation, Investigation. YL: Writing – review and editing, Data curation. LG: Funding acquisition, Project administration, Supervision, Writing – review and editing, Conceptualization.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by National Key Research and Development Project (2022YFC2704602 and 2022YFC2704502), National Natural Science Foundation of China (82120108011 and 82371699), and Major Project of Shanghai Municipal Education Commission Scientific Research and Innovation Plan (2021-01-07-00-07-E00144).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abu Samra, N., Jelinek, H. F., Alsafar, H., Asghar, F., Seoud, M., Hussein, S. M., et al. (2022). Genomics and epigenomics of gestational diabetes mellitus: understanding the molecular pathways of the disease pathogenesis. Int. J. Mol. Sci. 23 (7), 3514. doi:10.3390/ijms23073514
Aguirre, G. A., De Ita, J. R., De La Garza, R. G., and Castilla-Cortazar, I. (2016). Insulin-like growth factor-1 deficiency and metabolic syndrome. J. Transl. Med. 14, 3. doi:10.1186/s12967-015-0762-z
Bauer, M., Hutterer, G., Eder, M., Majer, S., Leshane, E., Johnson, K. L., et al. (2006). A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenat. Diagn 26 (9), 831–836. doi:10.1002/pd.1513
Camunas-Soler, J., Gee, E. P. S., Reddy, M., Mi, J. D., Thao, M., Brundage, T., et al. (2022). Predictive RNA profiles for early and very early spontaneous preterm birth. Am. J. Obstet. Gynecol. 227 (1), 72.e1–72.e16. doi:10.1016/j.ajog.2022.04.002
Carter, J. L., Stevens, H., Ridge, P. G., and Johnson, S. M. (2023). Short sequence aligner benchmarking for chromatin research. Int. J. Mol. Sci. 24 (18), 14074. doi:10.3390/ijms241814074
Chai, S. Y., Smith, R., Fitter, J. T., Mitchell, C., Pan, X., Ilicic, M., et al. (2014). Increased progesterone receptor A expression in labouring human myometrium is associated with decreased promoter occupancy by the histone demethylase JARID1A. Mol. Hum. Reprod. 20 (5), 442–453. doi:10.1093/molehr/gau005
Chai, S. Y., Smith, R., Zakar, T., Mitchell, C., and Madsen, G. (2012). Term myometrium is characterized by increased activating epigenetic modifications at the progesterone receptor-A promoter. Mol. Hum. Reprod. 18 (8), 401–409. doi:10.1093/molehr/gas012
Chawanpaiboon, S., Vogel, J. P., Moller, A. B., Lumbiganon, P., Petzold, M., Hogan, D., et al. (2019). Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob. Health 7 (1), e37–e46. doi:10.1016/s2214-109x(18)30451-0
Cruz, J. O., Conceição, I., Sandrim, V. C., and Luizon, M. R. (2022). Comprehensive analyses of DNA methylation of the TIMP3 promoter in placentas from early-onset and late-onset preeclampsia. Placenta 117, 118–121. doi:10.1016/j.placenta.2021.12.003
Deng, J., Zhao, H. J., Zhong, Y., Hu, C., Meng, J., Wang, C., et al. (2023). H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia. EBioMedicine 93, 104664. doi:10.1016/j.ebiom.2023.104664
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R. P. V., et al. (2023). Pre-eclampsia. Nat. Rev. Dis. Prim. 9 (1), 8. doi:10.1038/s41572-023-00417-6
Ehret, G. B., Munroe, P. B., Rice, K. M., Bochud, M., Johnson, A. D., Chasman, D. I., et al. (2011). Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478 (7367), 103–109. doi:10.1038/nature10405
Elovitz, M. A., Anton, L., Bastek, J., and Brown, A. G. (2015). Can microRNA profiling in maternal blood identify women at risk for preterm birth? Am. J. Obstet. Gynecol. 212 (6), 782.e1–782.e7825. doi:10.1016/j.ajog.2015.01.023
Fűri, I., Kalmár, A., Wichmann, B., Spisák, S., Schöller, A., Barták, B., et al. (2015). Cell free DNA of tumor origin induces a 'metastatic' expression profile in HT-29 cancer cell line. PLoS One 10 (7), e0131699. doi:10.1371/journal.pone.0131699
Gao, L., Rabbitt, E. H., Condon, J. C., Renthal, N. E., Johnston, J. M., Mitsche, M. A., et al. (2015). Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition. J. Clin. Investig. 125 (7), 2808–2824. doi:10.1172/jci78544
Gao, L., Wang, G., Liu, W. N., Kinser, H., Franco, H. L., and Mendelson, C. R. (2016). Reciprocal feedback between miR-181a and E(2)/erα in myometrium enhances inflammation leading to labor. J. Clin. Endocrinol. Metab. 101 (10), 3646–3656. doi:10.1210/jc.2016-2078
Haataja, R., Karjalainen, M. K., Luukkonen, A., Teramo, K., Puttonen, H., Ojaniemi, M., et al. (2011). Mapping a new spontaneous preterm birth susceptibility gene, IGF1R, using linkage, haplotype sharing, and association analysis. PLoS Genet. 7 (2), e1001293. doi:10.1371/journal.pgen.1001293
Hirota, Y., Daikoku, T., Tranguch, S., Xie, H., Bradshaw, H. B., and Dey, S. K. (2010). Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. J. Clin. Investigation 120 (3), 803–815. doi:10.1172/jci40051
Hong, X., Sherwood, B., Ladd-Acosta, C., Peng, S., Ji, H., Hao, K., et al. (2018). Genome-wide DNA methylation associations with spontaneous preterm birth in US blacks: findings in maternal and cord blood samples. Epigenetics 13 (2), 163–172. doi:10.1080/15592294.2017.1287654
Jain, V. G., Monangi, N., Zhang, G., and Muglia, L. J. (2022). Genetics, epigenetics, and transcriptomics of preterm birth. Am. J. Reprod. Immunol. 88 (4), e13600. doi:10.1111/aji.13600
Jakobsen, T. R., Clausen, F. B., Rode, L., Dziegiel, M. H., and Tabor, A. (2012). High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat. Diagn 32 (9), 840–845. doi:10.1002/pd.3917
Karjalainen, M. K., Huusko, J. M., Ulvila, J., Sotkasiira, J., Luukkonen, A., Teramo, K., et al. (2012). A potential novel spontaneous preterm birth gene, AR, identified by linkage and association analysis of X chromosomal markers. PLoS One 7 (12), e51378. doi:10.1371/journal.pone.0051378
Karjalainen, M. K., Ojaniemi, M., Haapalainen, A. M., Mahlman, M., Salminen, A., Huusko, J. M., et al. (2015). CXCR3 polymorphism and expression associate with spontaneous preterm birth. J. Immunol. 195 (5), 2187–2198. doi:10.4049/jimmunol.1501174
Ke, W., Chen, C., Luo, H., Tang, J., Zhang, Y., Gao, W., et al. (2016). Histone deacetylase 1 regulates the expression of progesterone receptor A during human parturition by occupying the progesterone receptor A promoter. Reprod. Sci. 23 (7), 955–964. doi:10.1177/1933719115625848
Kim, J., Pitlick, M. M., Christine, P. J., Schaefer, A. R., Saleme, C., Comas, B., et al. (2013). Genome-wide analysis of DNA methylation in human amnion. ScientificWorldJournal 2013, 678156. doi:10.1155/2013/678156
Kulkarni, A., Chavan-Gautam, P., Mehendale, S., Yadav, H., and Joshi, S. (2011). Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell. Biol. 30 (2), 79–84. doi:10.1089/dna.2010.1084
Leung, T. N., Zhang, J., Lau, T. K., Hjelm, N. M., and Lo, Y. M. (1998). Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352 (9144), 1904–1905. doi:10.1016/s0140-6736(05)60395-9
Li, C., Cao, M., and Zhou, X. (2022). Role of epigenetics in parturition and preterm birth. Biol. Rev. Camb Philos. Soc. 97 (3), 851–873. doi:10.1111/brv.12825
Liang, L., Rasmussen, M. H., Piening, B., Shen, X., Chen, S., Röst, H., et al. (2020). Metabolic dynamics and prediction of gestational age and time to delivery in pregnant women. Cell. 181 (7), 1680–1692.e15. doi:10.1016/j.cell.2020.05.002
Liu, X., Helenius, D., Skotte, L., Beaumont, R. N., Wielscher, M., Geller, F., et al. (2019). Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration. Nat. Commun. 10 (1), 3927. doi:10.1038/s41467-019-11881-8
Luo, X., Pan, J., Wang, L., Wang, P., Zhang, M., Liu, M., et al. (2015). Epigenetic regulation of lncRNA connects ubiquitin-proteasome system with infection-inflammation in preterm births and preterm premature rupture of membranes. BMC Pregnancy Childbirth 15, 35. doi:10.1186/s12884-015-0460-0
Mcintyre, T. I., Valdez, O., Kochhar, N. P., Davidson, B., Samad, B., Qiu, L., et al. (2025). KDM6B-dependent epigenetic programming of uterine fibroblasts in early pregnancy regulates parturition timing in mice. Cell. 188, 1265–1279.e18. doi:10.1016/j.cell.2024.12.019
Meister, S., Hahn, L., Beyer, S., Kuhn, C., Jegen, M., Von Schönfeldt, V., et al. (2021). Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia. J. Reprod. Immunol. 145, 103287. doi:10.1016/j.jri.2021.103287
Moufarrej, M. N., Wong, R. J., Shaw, G. M., Stevenson, D. K., and Quake, S. R. (2020). Investigating pregnancy and its complications using circulating cell-free RNA in women's blood during gestation. Front. Pediatr. 8, 605219. doi:10.3389/fped.2020.605219
Ngo, T. T. M., Moufarrej, M. N., Rasmussen, M. H., Camunas-Soler, J., Pan, W., Okamoto, J., et al. (2018). Noninvasive blood tests for fetal development predict gestational age and preterm delivery. Science 360 (6393), 1133–1136. doi:10.1126/science.aar3819
Palomares, K. T., Parobchak, N., Ithier, M. C., Aleksunes, L. M., Castaño, P. M., So, M., et al. (2021). Fetal exosomal platelet-activating factor triggers functional progesterone withdrawal in human placenta. Reprod. Sci. 28 (1), 252–262. doi:10.1007/s43032-020-00283-7
Phillippe, M. (2014). Cell-free fetal DNA--a trigger for parturition. N. Engl. J. Med. 370 (26), 2534–2536. doi:10.1056/NEJMcibr1404324
Pieber, D., Allport, V. C., Hills, F., Johnson, M., and Bennett, P. R. (2001). Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol. Hum. Reprod. 7 (9), 875–879. doi:10.1093/molehr/7.9.875
Pineles, B. L., Romero, R., Montenegro, D., Tarca, A. L., Han, Y. M., Kim, Y. M., et al. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196 (3), 261.e1–261.e2616. doi:10.1016/j.ajog.2007.01.008
Renthal, N. E., Chen, C. C., Williams, K. C., Gerard, R. D., Prange-Kiel, J., and Mendelson, C. R. (2010). miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc. Natl. Acad. Sci. U. S. A. 107 (48), 20828–20833. doi:10.1073/pnas.1008301107
Renthal, N. E., Williams, K. C., and Mendelson, C. R. (2013). MicroRNAs--mediators of myometrial contractility during pregnancy and labour. Nat. Rev. Endocrinol. 9 (7), 391–401. doi:10.1038/nrendo.2013.96
Romero, R., Dey, S. K., and Fisher, S. J. (2014). Preterm labor: one syndrome, many causes. Science 345 (6198), 760–765. doi:10.1126/science.1251816
Subramanian, A., Weiss, D., Nyhan, K., Dewan, A., and Jukic, A. M. Z. (2023). Circulating miRNAs in the first trimester and pregnancy complications: a systematic review. Epigenetics 18 (1), 2152615. doi:10.1080/15592294.2022.2152615
Tarca, A. L., Pataki, B., Romero, R., Sirota, M., Guan, Y., Kutum, R., et al. (2021). Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth. Cell. Rep. Med. 2 (6), 100323. doi:10.1016/j.xcrm.2021.100323
Van Boeckel, S. R., Davidson, D. J., Norman, J. E., and Stock, S. J. (2018). Cell-free fetal DNA and spontaneous preterm birth. Reproduction 155 (3), R137–r145. doi:10.1530/rep-17-0619
Vogel, J. P., Chawanpaiboon, S., Moller, A. B., Watananirun, K., Bonet, M., and Lumbiganon, P. (2018). The global epidemiology of preterm birth. Best. Pract. Res. Clin. Obstet. Gynaecol. 52, 3–12. doi:10.1016/j.bpobgyn.2018.04.003
Wang, H., Ogawa, M., Wood, J. R., Bartolomei, M. S., Sammel, M. D., Kusanovic, J. P., et al. (2008). Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum. Mol. Genet. 17 (8), 1087–1096. doi:10.1093/hmg/ddm381
Wang, Z., Ou, Q., and Gao, L. (2023). The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. Front. Immunol. 14, 1154025. doi:10.3389/fimmu.2023.1154025
Williams, K. C., Renthal, N. E., Condon, J. C., Gerard, R. D., and Mendelson, C. R. (2012). MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc. Natl. Acad. Sci. U. S. A. 109 (19), 7529–7534. doi:10.1073/pnas.1200650109
Wu, Y., Lin, X., Lim, I. Y., Chen, L., Teh, A. L., Macisaac, J. L., et al. (2019). Analysis of two birth tissues provides new insights into the epigenetic landscape of neonates born preterm. Clin. Epigenetics 11 (1), 26. doi:10.1186/s13148-018-0599-4
Yang, Z., Slone, J., Wang, X., Zhan, J., Huang, Y., Namjou, B., et al. (2021). Validation of low-coverage whole-genome sequencing for mitochondrial DNA variants suggests mitochondrial DNA as a genetic cause of preterm birth. Hum. Mutat. 42 (12), 1602–1614. doi:10.1002/humu.24279
Zhang, G., Feenstra, B., Bacelis, J., Liu, X., Muglia, L. M., Juodakis, J., et al. (2017). Genetic associations with gestational duration and spontaneous preterm birth. N. Engl. J. Med. 377 (12), 1156–1167. doi:10.1056/NEJMoa1612665
Zhao, X., Dong, X., Luo, X., Pan, J., Ju, W., Zhang, M., et al. (2017). Ubiquitin-Proteasome-collagen (CUP) pathway in preterm premature rupture of fetal membranes. Front. Pharmacol. 8, 310. doi:10.3389/fphar.2017.00310
Keywords: labor, preterm birth, genetics, epigenetics, term labor
Citation: Sun K, Wang N, Liu Y and Gao L (2025) Regulation of term and preterm labor: genetics and epigenetics. Front. Genet. 16:1594030. doi: 10.3389/fgene.2025.1594030
Received: 17 March 2025; Accepted: 05 June 2025;
Published: 18 June 2025.
Edited by:
Alessandro Fiorenzano, Lund University, SwedenReviewed by:
Srirupa Hari Gopal, SSM Health Saint Louis University Hospital, United StatesCopyright © 2025 Sun, Wang, Liu and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lu Gao, cm9hZGdhb0AxNjMuY29t